65597-407 : Turalio 125 mg Oral Capsule


NDC: 65597-407
Labeler: Daiichi Sankyo, Inc.
Product Type: Human Prescription Drug
Drug Name:  Turalio
Dosage Form: Oral Capsule
Application #: NDA211810
Rev. Date: 


NDC Package Codes:

  • 65597-407-20: 1 BOTTLE IN 1 CARTON (65597‑407‑20) / 120 CAPSULE IN 1 BOTTLE
  • 65597-407-28: 1 BOTTLE IN 1 CARTON (65597‑407‑28) / 28 CAPSULE IN 1 BOTTLE

Active Ingredients:

  • Pexidartinib Hydrochloride

Dosage Strength:

  • 125 mg

Pharmaceutical Classes:

  • Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]
  • Cytochrome P450 2B6 Inhibitors [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]
  • Tyrosine Kinase Inhibitors [MoA]
  • UGT1A1 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 65597-402 Turalio 200 mg Oral Capsule by Daiichi Sankyo Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65597-407 QR Code

< Prev: 65597-406Next: 65597-501 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.